Literature DB >> 15729574

Activation of 12-lipoxygenase in proinflammatory cytokine-mediated beta cell toxicity.

M Chen1, Z D Yang, K M Smith, J D Carter, J L Nadler.   

Abstract

AIMS/HYPOTHESIS: Beta cell inflammation and cytokine-induced toxicity are central to autoimmune diabetes development. Lipid mediators generated upon lipoxygenase (LO) activation can participate in inflammatory pathways. 12LO-deficient mice are resistant to streptozotocin-induced diabetes. This study sought to characterise the cellular processes involving 12LO-activation lipid inflammatory mediator production in cytokine-treated pancreatic beta cells.
METHODS: Islets and beta cell lines were treated with a combination of IL-1beta, IFN-gamma and TNF-alpha, or the 12LO product 12(S)-hydroxyeicosatetraenoic acid (HETE). Insulin secretion was measured using an enzyme immunoassay, and cell viability was evaluated using an in situ terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling assay. 12LO activity was evaluated and 12LO protein levels were determined using immunoblotting with a selective leucocyte type 12LO antibody. Cellular localisation of 12LO was evaluated using immunocytochemistry.
RESULTS: Basal expression of leucocyte type 12LO protein was found in human and mouse islets and in several rodent beta cell lines. In mouse beta-TC3 cells, and in human islets, cytokines induced release of 12-HETE within 30 min. Cytokine addition also induced a rapid translocation of 12LO protein from the cytosol to the nucleus of beta-TC3 cells as shown by subcellular fractionation and immunostaining. Cytokine-induced cell death and inhibition of insulin secretion were partially reversed by baicalein, a 12LO inhibitor. 12(S)-HETE inhibited beta-TC3 cell insulin release in a time- and concentration-dependent manner. Incubating beta-TC3 cells with 100 nmol/l of 12(S)-HETE resulted in a 57% reduction in basal insulin release (6 h), and a 17% increase in cell death (18 h) as compared with untreated cells. 12(S)-HETE activated the stress-activated protein kinase c-Jun N-terminal kinase and p38 within 15 min, as judged by increased kinase protein phosphorylation. CONCLUSIONS/
INTERPRETATION: The data suggest that inflammatory cytokines rapidly activate 12LO and show for the first time that cytokines induce 12LO translocation. The effects of 12-HETE on insulin secretion, cytotoxicity and kinase activation were similar to the effects seen with cytokines. The results provide mechanistic information of cytokine-induced toxic effects on pancreatic beta cells and support the hypothesis that blocking 12LO activation could provide a new therapeutic way to protect pancreatic beta cells from autoimmune injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15729574     DOI: 10.1007/s00125-005-1673-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  49 in total

Review 1.  beta-cell apoptosis: stimuli and signaling.

Authors:  T Mandrup-Poulsen
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

Review 2.  12/15-lipoxygenase, oxidative modification of LDL and atherogenesis.

Authors:  C D Funk; T Cyrus
Journal:  Trends Cardiovasc Med       Date:  2001 Apr-May       Impact factor: 6.677

Review 3.  Arachidonate 12-lipoxygenases.

Authors:  S Yamamoto; H Suzuki; N Ueda
Journal:  Prog Lipid Res       Date:  1997-03       Impact factor: 16.195

Review 4.  The arachidonate 12/15 lipoxygenases. A review of tissue expression and biologic function.

Authors:  D J Conrad
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

5.  Lipoxygenase products increase monocyte adhesion to human aortic endothelial cells.

Authors:  M K Patricia; J A Kim; C M Harper; P T Shih; J A Berliner; R Natarajan; J L Nadler; C C Hedrick
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-11       Impact factor: 8.311

6.  Augmented insulinotropic action of arachidonic acid through the lipoxygenase pathway in the obese Zucker rat.

Authors:  B Ahrén; L J Magrum; P J Havel; S F Greene; S D Phinney; P R Johnson; J S Stern
Journal:  Obes Res       Date:  2000-09

7.  Regulation of 12-lipoxygenase by cytokines in vascular smooth muscle cells.

Authors:  R Natarajan; J Rosdahl; N Gonzales; W Bai
Journal:  Hypertension       Date:  1997-10       Impact factor: 10.190

8.  Intercellular differences in interleukin 1beta-induced suppression of insulin synthesis and stimulation of noninsulin protein synthesis by rat pancreatic beta-cells.

Authors:  Z Ling; M C Chen; A Smismans; D Pavlovic; F Schuit; D L Eizirik; D G Pipeleers
Journal:  Endocrinology       Date:  1998-04       Impact factor: 4.736

9.  Arachidonic acid metabolism in isolated pancreatic islets. I. Identification and quantitation of lipoxygenase and cyclooxygenase products.

Authors:  J Turk; J R Colca; N Kotagal; M L McDaniel
Journal:  Biochim Biophys Acta       Date:  1984-06-06

10.  Interleukin-1 enhances pancreatic islet arachidonic acid 12-lipoxygenase product generation by increasing substrate availability through a nitric oxide-dependent mechanism.

Authors:  Z Ma; S Ramanadham; J A Corbett; A Bohrer; R W Gross; M L McDaniel; J Turk
Journal:  J Biol Chem       Date:  1996-01-12       Impact factor: 5.157

View more
  43 in total

1.  Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation.

Authors:  Roman Stavniichuk; Viktor R Drel; Hanna Shevalye; Yury Maksimchyk; Tamara M Kuchmerovska; Jerry L Nadler; Irina G Obrosova
Journal:  Exp Neurol       Date:  2011-04-16       Impact factor: 5.330

Review 2.  Functional and pathological roles of the 12- and 15-lipoxygenases.

Authors:  Anca D Dobrian; David C Lieb; Banumathi K Cole; David A Taylor-Fishwick; Swarup K Chakrabarti; Jerry L Nadler
Journal:  Prog Lipid Res       Date:  2010-10-21       Impact factor: 16.195

3.  ALOX12 in human toxoplasmosis.

Authors:  William H Witola; Susan Ruosu Liu; Alexandre Montpetit; Ruth Welti; Magali Hypolite; Mary Roth; Ying Zhou; Ernest Mui; Marie-France Cesbron-Delauw; Gilbert J Fournie; Pierre Cavailles; Cordelia Bisanz; Kenneth Boyer; Shawn Withers; A Gwendolyn Noble; Charles N Swisher; Peter T Heydemann; Peter Rabiah; Stephen P Muench; Rima McLeod
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

Review 4.  Eicosanoids, β-cell function, and diabetes.

Authors:  Pengcheng Luo; Mong-Heng Wang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-07-03       Impact factor: 3.072

5.  Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats.

Authors:  Swarup K Chakrabarti; Yeshao Wen; Anca D Dobrian; Banumathi K Cole; Qian Ma; Hong Pei; Michael D Williams; Melissa H Bevard; George E Vandenhoff; Susanna R Keller; Jiali Gu; Jerry L Nadler
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-26       Impact factor: 4.310

6.  Synthesis and structure-activity relationship studies of 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase.

Authors:  Diane K Luci; J Brian Jameson; Adam Yasgar; Giovanni Diaz; Netra Joshi; Auric Kantz; Kate Markham; Steve Perry; Norine Kuhn; Jennifer Yeung; Edward H Kerns; Lena Schultz; Michael Holinstat; Jerry L Nadler; David A Taylor-Fishwick; Ajit Jadhav; Anton Simeonov; Theodore R Holman; David J Maloney
Journal:  J Med Chem       Date:  2014-01-06       Impact factor: 7.446

7.  12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by Western diet.

Authors:  Craig S Nunemaker; Meng Chen; Hong Pei; Sarah D Kimble; Susanna R Keller; Jeffrey D Carter; Zandong Yang; Kellie M Smith; Runpei Wu; Melissa H Bevard; James C Garmey; Jerry L Nadler
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-09-09       Impact factor: 4.310

Review 8.  Bioactive lipids and pathological retinal angiogenesis.

Authors:  Khaled Elmasry; Ahmed S Ibrahim; Samer Abdulmoneim; Mohamed Al-Shabrawey
Journal:  Br J Pharmacol       Date:  2018-11-19       Impact factor: 8.739

9.  Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes.

Authors:  Hang Yuan; Linda Lanting; Zhong-Gao Xu; Shu-Lian Li; Piotr Swiderski; Sumanth Putta; Mahesh Jonnalagadda; Mitsuo Kato; Rama Natarajan
Journal:  Am J Physiol Renal Physiol       Date:  2008-06-18

10.  12-Lipoxygenase Products Reduce Insulin Secretion and {beta}-Cell Viability in Human Islets.

Authors:  K Ma; C S Nunemaker; R Wu; S K Chakrabarti; D A Taylor-Fishwick; J L Nadler
Journal:  J Clin Endocrinol Metab       Date:  2010-01-20       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.